Form CORRESP - Correspondence:
SEC Accession No. 0001753926-21-000332
Filing Date
2021-08-11
Accepted
2021-08-11 21:52:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 35847
  Complete submission text file 0001753926-21-000332.txt   36734
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations